Perrigo Announces FDA Approval for the Store Brand Equivalent ofPRGO: Perrigo Company plc
2020-04-06 08:30:00
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren® Arthritis Pain
PIG trade ideas
Perrigo Company Breakout on FDA approval
Perrigo (PRGO) and its partner, Catalent Pharma Solutions (CTLT) announced that the FDA has approved Perrigo's abbreviated new drug application for generic albuterol sulfate inhalation aerosol, the first AB-rated generic version of ProAir HFA. Perrigo is launching a limited quantity of generic albuterol sulfate inhalation aerosol and, in collaboration with its development and manufacturing partner Catalent, is ramping up production to meet future demand. Generic albuterol sulfate inhalation aerosol is indicated in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. ProAir HFA gross sales for the previous 12 months were approximately $1.4 billion, as measured by IQVIA. Source thefly
Perrigo (PRGO -1%) agrees to acquire the oral care assets of High Ridge Brands for $113M, subject to bankruptcy court approval in connection with High Ridge's Chapter 11 cases.
Perrigo expects the assets will contribute more than $100M in net sales and be accretive to earnings in first full-year post closing.
The acquisition builds upon Perrigo's July 2019 purchase of Ranir, the world's largest private-label oral self-care company.
Source seeking alpha
Company profile
Perrigo Co. Plc is a healthcare company, which engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals. The Consumer Healthcare Americas segment comprises the U.S., Mexico and Canada consumer healthcare business. The Consumer Healthcare International segment includes branded consumer healthcare business primarily in Europe and consumer focused businesses in the U.K., Australia, and Israel. The Prescription Pharmaceuticals refers to the U.S. prescription pharmaceuticals business. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland.
Perrigo. Oversold stock with good opportunity to buy?Might try to buy some near $50. Target price $150-200. The company also pays quite stable dividends, albeit small ones. This stock is more designed for growth, keep this in mind.
PRGO: Such a beaten down name and this could move this er.$54 is such a old trend line and don't think that can be taken out but can get there. Prices marked.
Buy PRGO here...place sell stop at 72.89...risk/reward is 3.5 toPRGO broke to the upside out of a Market Profile pattern. Target is 77.87 which makes it about a 3.5 to 1 trade. Relative Out Performance vs SP is 1.64 % on a 10 day average (smoothed over past 50 days)
Short term target zone reached - Resistance aheadTo continue higher PRGO will have to break above the top of the channel and the 200 MA line.
Bears can look for bearish reversal signs inside this resistance zone.
Long prgo - reverse swing PRGO looks very nice for a big reverse swing up the gop's failed attempt to replace obamacare should help our cause here
Nice channel play - call options I love this channel play for call options, specially for you smaller accounts. Get in right at the bell today or see if it hits $86 in the morning or Monday, trade your plan!!! I would use a stop of $84.
Never catch a falling knife......unless it has hit the ground. Today's steep fall hit the monthly support. I guess that this may be a temporary bottom at least. So that I assume that we may see a correction up from here.
PRGO SqueezePRGO is showing that it could make a move to the upside. Squeeze shows it firing higher, plus 9 MA just crossed the 21.
